Alzheimer's Disease Research Foundation D/b/a Cure Alzheimer's Fund

UNIVERSITY OF CONNECTICUT

AD PATHOPHYSIOLOGY ALTERS THE LEVEL OF ELECTRICAL AND CHEMICAL SYNAPSE COUPLING IN THE NETWORK OF GABAERGIC PV+ INTERNEURONS EARLY IN DISEASE COURSE

• 2022

WASHINGTON UNIVERSITY

APOE: ASSESSING THE ADDED DIAGNOSTIC VALUE OF PERIPHERAL APOE PROTEIN LEVELS IN CURRENT BLOOD-BASED BIOMARKER ASSAYS FOR CNS AMYLOIDOSIS

• 2022

YALE

BEE: CNS FLUID HOMEOSTASIS AND WASTE CLEARANCE IN ALZHEIMERS DISEASE CHARACTERIZED BY MRI

• 2022

MASSACHUSETTS GENERAL HOSPITAL

EFFECTS OF DE-PALMITOYLATION AND ACAT INHIBITION ON AXONAL AB GENERATION VIA MAM-ASSOCIATED PALAPP

• 2022

DUKE

CONTRIBUTIONS OF IL34 SIGNALING TO MICROGLIAL FUNCTION AND ALZHEIMERS PATHOLOGY IN MICE

• 2022

MOUNT SINAI

ESTABLISHING THE MOLECULAR AND CELLULAR MECHANISMS AND BIOMARKERS OF APOE4-MEDIATED SUSCEPTIBILITY TO TAU-RELATED COGNITIVE IMPAIRMENTS

• 2022

UNIVERSITY OF VIRGINIA

TOXIC EFFECTS OF EXTRACELLULAR TAU OLIGOMERS ON NEURONS

• 2022

UNIVERSITY OF CALIFORNIA IRVINE

NIC: EXAMINING THE ROLE OF HUMAN MICROGLIA IN THE TRANSITION BETWEEN PARENCHYMAL AND VASCULAR BETA-AMYLOID PATHOLOGY

• 2022

UNIVERSITY OF SOUTHERN CALIFORNIA

PRENATAL INFLAMMATION EFFECTS ON BLOOD BRAIN BARRIER FUNCTION AND AD-RELATED PATHOLOGIES ACROSS THE LIFESPAN

• 2022

BRIGHAM AND WOMEN'S

APOE CONSORTIUM: APOE4-MEDIATED DYSFUNCTION OF CD8 T CELL-MICROGLIA CROSSTALK IN ALZHEIMERS DISEASE

• 2022